Literature DB >> 26603547

A comparative evaluation of risk-adjustment models for benchmarking amputation-free survival after lower extremity bypass.

Jessica P Simons1, Philip P Goodney2, Julie Flahive1, Andrew W Hoel3, John W Hallett4, Larry W Kraiss5, Andres Schanzer6.   

Abstract

BACKGROUND: Providing patients and payers with publicly reported risk-adjusted quality metrics for the purpose of benchmarking physicians and institutions has become a national priority. Several prediction models have been developed to estimate outcomes after lower extremity revascularization for critical limb ischemia, but the optimal model to use in contemporary practice has not been defined. We sought to identify the highest-performing risk-adjustment model for amputation-free survival (AFS) at 1 year after lower extremity bypass (LEB).
METHODS: We used the national Society for Vascular Surgery Vascular Quality Initiative (VQI) database (2003-2012) to assess the performance of three previously validated risk-adjustment models for AFS. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL), Finland National Vascular (FINNVASC) registry, and the modified Project of Ex-vivo vein graft Engineering via Transfection III (PREVENT III [mPIII]) risk scores were applied to the VQI cohort. A novel model for 1-year AFS was also derived using the VQI data set and externally validated using the PIII data set. The relative discrimination (Harrell c-index) and calibration (Hosmer-May goodness-of-fit test) of each model were compared.
RESULTS: Among 7754 patients in the VQI who underwent LEB for critical limb ischemia, the AFS was 74% at 1 year. Each of the previously published models for AFS demonstrated similar discriminative performance: c-indices for BASIL, FINNVASC, mPIII were 0.66, 0.60, and 0.64, respectively. The novel VQI-derived model had improved discriminative ability with a c-index of 0.71 and appropriate generalizability on external validation with a c-index of 0.68. The model was well calibrated in both the VQI and PIII data sets (goodness of fit P = not significant).
CONCLUSIONS: Currently available prediction models for AFS after LEB perform modestly when applied to national contemporary VQI data. Moreover, the performance of each model was inferior to that of the novel VQI-derived model. Because the importance of risk-adjusted outcome reporting continues to increase, national registries such as VQI should begin using this novel model for benchmarking quality of care.
Copyright © 2016 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26603547      PMCID: PMC5315434          DOI: 10.1016/j.jvs.2015.09.051

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study.

Authors:  Fausto Biancari; Juha-Pekka Salenius; Maarit Heikkinen; Michael Luther; Kari Ylönen; Mauri Lepäntalo
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

2.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.

Authors:  Andrew W Bradbury; Donald J Adam; Jocelyn Bell; John F Forbes; F Gerry R Fowkes; Ian Gillespie; Charles Vaughan Ruckley; Gillian M Raab
Journal:  J Vasc Surg       Date:  2010-05       Impact factor: 4.268

Review 3.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.

Authors:  Michael S Conte
Journal:  J Vasc Surg       Date:  2010-05       Impact factor: 4.268

4.  Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia.

Authors:  Eva Arvela; Maria Söderström; Maria Korhonen; Karoliina Halmesmäki; Anders Albäck; Mauri Lepäntalo; Maarit Venermo; Fausto Biancari
Journal:  J Vasc Surg       Date:  2010-08-14       Impact factor: 4.268

5.  Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.

Authors:  Michael S Conte; Dennis F Bandyk; Alexander W Clowes; Gregory L Moneta; Lynn Seely; Todd J Lorenz; Hamid Namini; Allen D Hamdan; Sean P Roddy; Michael Belkin; Scott A Berceli; Richard J DeMasi; Russell H Samson; Scott S Berman
Journal:  J Vasc Surg       Date:  2006-04       Impact factor: 4.268

6.  Validation of the Finnvasc score in infrainguinal percutaneous transluminal angioplasty for critical lower limb ischemia.

Authors:  Aristotelis Kechagias; Jukka Perälä; Kari Ylönen; Muhammad Ali Asim Mahar; Fausto Biancari
Journal:  Ann Vasc Surg       Date:  2008-04-03       Impact factor: 1.466

7.  Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.

Authors:  Andres Schanzer; Philip P Goodney; Youfu Li; Mohammad Eslami; Jack Cronenwett; Louis Messina; Michael S Conte
Journal:  J Vasc Surg       Date:  2009-07-22       Impact factor: 4.268

8.  The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores.

Authors:  Paul W Moxey; Jack Brownrigg; Sharanya S Kumar; Georgina Crate; Peter J Holt; Matt M Thompson; Keith G Jones; Robert J Hinchliffe
Journal:  J Vasc Surg       Date:  2012-10-05       Impact factor: 4.268

9.  Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.

Authors:  Andres Schanzer; Jessica Mega; Judith Meadows; Russell H Samson; Dennis F Bandyk; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-12       Impact factor: 4.268

Review 10.  Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.

Authors:  Michael S Conte; Patrick J Geraghty; Andrew W Bradbury; Nathanael D Hevelone; Stuart R Lipsitz; Gregory L Moneta; Mark R Nehler; Richard J Powell; Anton N Sidawy
Journal:  J Vasc Surg       Date:  2009-11-07       Impact factor: 4.268

  10 in total
  2 in total

1.  Cardiovascular and Limb Events Following Endovascular Revascularization Among Patients ≥65 Years Old: An American College of Cardiology PVI Registry Analysis.

Authors:  E Hope Weissler; Yongfei Wang; Jordan M Gales; Dmitriy N Feldman; Shipra Arya; Eric A Secemsky; Herbert D Aronow; Beau M Hawkins; J Antonio Gutierrez; Manesh R Patel; Jeptha P Curtis; W Schuyler Jones; Rajesh V Swaminathan
Journal:  J Am Heart Assoc       Date:  2022-06-20       Impact factor: 6.106

Review 2.  Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.

Authors:  Federico Biscetti; Elisabetta Nardella; Maria Margherita Rando; Andrea Leonardo Cecchini; Antonio Gasbarrini; Massimo Massetti; Andrea Flex
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.